Synonyms: OPN-305
Tomaralimab (Anti-TLR2 / CD282) is a humanized immunoglobulin (Ig) G4 monoclonal antibody directed against toll-like receptor type 2 (TLR2) with potential anti-inflammatory and antineoplastic activities. It has the potential for research on Myelodysplastic Syndromes (MDS). MW : 145.5 KD.
| Name | Citation | TLR7 | TLR8 | TLR9 | TLR4 | TLR2 | TLR3 | TLR1 | Others |
|---|---|---|---|---|---|---|---|---|---|
| Enpatoran Hydrochloride | 0 | ||||||||
| CU-CPT-8m | 1 | ||||||||
| CU-CPT9a | 2 | ||||||||
| MD2-IN-1 | 3 | ||||||||
| CU-CPT22 | 9 | ||||||||
| Okanin | 0 | NF-κB | |||||||
| AMG-9810 | 1 | hTRPV1,rTRPV1 | |||||||
| TLR4-IN-C34 | 7 | ||||||||
| E6446 | 5 | DNA-TLR9 | |||||||
| TLR2-IN-C29 | 21 | ||||||||
| MD2-TLR4-IN-1 | 0 | IL-6,TNF-α | |||||||
| IAXO-102 | 0 | NF-κB,MAPK | |||||||
| E6446 Dihydrochloride | 4 | ||||||||
| Resatorvid (TAK-242) | 63 | IL-6,NO,TNF-α | |||||||
| Ginsenoside Rb1 | 4 | IFN-β,TNF-α,NF-κB |
| Description |
Tomaralimab (Anti-TLR2 / CD282) is a humanized immunoglobulin (Ig) G4 monoclonal antibody directed against toll-like receptor type 2 (TLR2) with potential anti-inflammatory and antineoplastic activities. It has the potential for research on Myelodysplastic Syndromes (MDS). MW : 145.5 KD.
|
|---|
| CAS No. | 1449294-76-1 |
|---|---|
| Molecular Weight | 145.5 kDa |
| Isotype | Human IgG4SP |
| Source | CHO |
| Purification | AKTA |
| Sterility | 0.2 μM filtered |
| Formulation | 100 mM Pro-Ac, 20mM Arg, pH5.0 |
| Storage (From the date of receipt) |
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles. |
*Literature analysis of various clone (for this target) products available on the market shows that Selleck's selected clones are more frequently applied. (data until September 2024)
Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.